Rush Presbyterian St. Lukes Hospital has 1 portfolio company on record at Recent Funding. Its most recent investment on record is Transcarent's $200M Series B+ round in January 2022, alongside Threshold Ventures, Northwell Health, Merck Global Health Innovation Fund and 6 others. That company is in Health and bio.

What Rush Presbyterian St. Lukes Hospital invests in

• Health and bio · 1 · 100%
• HR and recruiting · 1 · 100%

How Rush Presbyterian St. Lukes Hospital invests

Share is of the 1 round on Recent Funding that name Rush Presbyterian St. Lukes Hospital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Rush Presbyterian St. Lukes Hospital portfolio companies

• TTranscarent$200MSeries B+ · Jan 2022

Most frequent co-investors

• GGeneral Catalyst1 shared round · last Jan 11, 2022
• TThreshold Ventures1 shared round · last Jan 11, 2022
• GGreatPoint Ventures1 shared round · last Jan 11, 2022
• HHuman Capital1 shared round · last Jan 11, 2022
• KKinnevik1 shared round · last Jan 11, 2022
• JJove Equity Partners1 shared round · last Jan 11, 2022
• MMerck Global Health Innovation Fund1 shared round · last Jan 11, 2022
• NNorthwell Health1 shared round · last Jan 11, 2022
• IIntermountain Healthcare1 shared round · last Jan 11, 2022

Similar investors

• AAccelia Capital1 company · 1 deal in 12 mo
• BBioGenerator Ventures1 company · 1 deal in 12 mo
• BBiospring Partners1 company · 1 deal in 12 mo
• CColossa Ventures1 company · 1 deal in 12 mo
• FFirst Imagine!1 company · 1 deal in 12 mo
• MMaxis1 company · 1 deal in 12 mo

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Rush Presbyterian St. Lukes Hospital, which is a subset of its real portfolio. API: /api/v1/investors/rush-presbyterian-st-lukes-hospital (get a free API key). More: the most active VC firms and new venture capital funds.